Brian G. Murphy
Chairman of the Board
General Partner of Commerce
Health Ventures
Mr. Murphy is a General Partner of Commerce Health Ventures, Partner of NewSpring Ventures, and a Partner of NewSpring Capital, with more than 20 years of corporate management and development experience, focused primarily in healthcare services. He has a strong background in business strategy, investment structuring, organizational growth, and negotiation of mergers and acquisitions.  
More Info

Mark D. Myslinski
President and CEO,
RedPath Integrated Pathology, Inc.
Mr. Myslinski brings nearly thirty years of life sciences and diagnostics industry experience to RedPath, including key sales and operating roles in both Fortune 100 and venture-backed start-up organizations. Mr. Myslinski has been a Johnson & Johnson executive since 2002 where his responsibilities have included building a new, world-wide Evidence Based Medicine function for the Ortho-Clinical Diagnostics unit. For five years, Mr. Myslinski was also General Manager of Johnson & Johnson's Veridex, LLC, a division focused on molecular and cellular diagnostics that achieved rapid sales growth under Mr. Myslinski's tenure. Previously, Mr. Myslinski held executive roles in venture-backed start-ups, Interscope Technologies and Precision Therapeutics, both focused on the field of pathology with an emphasis on cancer. Mr. Myslinski also accumulated over twenty years of sales and marketing experience prior to these roles, including over eight years with Baxter/American Hospital Supply Corporation. More Info

Peter G. Kleinhenz
Managing Director of CID Capital
Peter Kleinhenz is a Managing Director of CID Capital. He has been actively involved in technology-based businesses as an entrepreneur, consultant, and investor for over twenty-five years and has provided leadership for new venture formation in the life sciences sector for over 20 years. Peter leads the firm's investments in health care technology.
More Info

Dennis M. Smith Jr., M.D.
Chief Medical Officer
Dr. Smith possesses over 25 years of experience in healthcare management, the outreach laboratory business, pathology, laboratory medicine, and blood banking. He is a board-certified clinical and anatomic pathologist and transfusion medicine specialist. Dr. Smith's professional career includes serving on the executive management team and Board of Directors of AmeriPath, Inc. While at AmeriPath, Dr. Smith's positions included Chief Medical Officer, Executive Vice-President of Genomic Strategies, and Executive Director of AmeriPath's Center for Advanced Diagnostics. More Info

Jack Davis
Mr. Davis brings more than forty years experience in Life Science executive management to RedPath. He has helped entrepreneurs and investors bring their breakthrough technologies to the market for the benefit of cancer patients and their health care providers. Mr. Davis’ professional career includes co-founder, President/COO and later CEO, of Dianon Systems, Inc., which he built from a venture capital backed start-up to a $200 million leading provider of cutting edge Clinical and Anatomic Pathology based solutions for clinicians.  Previously, he was the Division Vice President and General Manager of Abbot Diagnostic’s $100 million worldwide Diagnostic Products business unit. Mr. Davis has also served on the Board of Directors of over twelve companies; taken two companies public as CEO and sold three other companies as either Chairman or Director. More Info

Sydney D. Finkelstein, M.D.
Founder and Chief Scientific Officer,
RedPath Integrated Pathology, Inc.
Dr. Finkelstein founded RedPath after having spent 20 years as a practicing academic surgical pathologist holding appointments as Associate and then Full Professor at the University of Pittsburgh (1993-1997, 1998-2002) and at Hahnemann University (1983-1993).  Dr. Finkelstein is a nationally recognized expert in both Gastrointestinal Pathology and Solid Tissue Molecular Pathology. He has published over 142 scientific manuscripts in peer-reviewed journals and has presented his work at international forums. Dr. Finkelstein brings together the unique attributes of creative innovative molecular pathology development as well as solid foundational understanding of the practice of modern surgical pathology practice. More Info

Rajesh U. Kothari, CFA
Co-Founder & Managing Director, Seneca Partners
With over fifteen years of investment and transaction experience, Mr. Kothari has spent his career analyzing, structuring, negotiating, monitoring and exiting a variety of transactions in the public and private markets.  Mr. Kothari is a co-founder and Managing Director of Seneca Partners, a venture capital and merchant-banking firm.  In addition to assisting companies with mergers, acquisitions, divestitures and corporate finance activities, Seneca Partners manages Seneca Health Partners, a venture capital fund dedicated to emerging healthcare companies located throughout Middle America.  More Info

Charles Resnick
Managing Partner, Inflexion Fund
Charles is an accomplished business executive with a 25-year career in global general management, operations, financial management, and strategic relationships in the technology, banking and consumer packaged goods sectors. Charles has had senior management positions in the United States, South America, Mexico, and Western Europe with Dank Business Systems, Tropicana Products, Mellon Bank, PepsiCo and The Procter & Gamble Company.
More Info